Group 1 - The core point of the article is that Meino Biological (SZ 301156) announced the convening of its fifth board meeting on October 27, 2025, to discuss the mid-term profit distribution plan for 2025 [1] - For the year 2024, Meino Biological's revenue composition is entirely from the feed industry, accounting for 100.0% [1] - As of the report date, Meino Biological has a market capitalization of 2.6 billion yuan [1]

Group 1 - Meino Bio announced that it will accept investor research on September 20, 2025, with participation from General Manager Xiao Weiwei and Board Secretary Zhang Weiwei [1] - For the year 2024, Meino Bio's revenue composition is 100% from the feed industry [1]